Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 421

Similar articles for PubMed (Select 11948235)

1.

Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.

Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB.

J Neurochem. 2002 Mar;80(5):727-35. Review.

PMID:
11948235
2.

Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.

Mukherji M, Kershaw NJ, Schofield CJ, Wierzbicki AS, Lloyd MD.

Chem Biol. 2002 May;9(5):597-605.

3.

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.

Mukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD.

Hum Mol Genet. 2001 Sep 1;10(18):1971-82.

4.

Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.

Wierzbicki AS.

Biochem Soc Trans. 2007 Nov;35(Pt 5):881-6. Review.

PMID:
17956237
5.

Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.

Wanders RJ, Komen JC.

Biochem Soc Trans. 2007 Nov;35(Pt 5):865-9. Review.

PMID:
17956234
7.

[Refsum's disease: evolution 35 years after diagnosis].

Marcaud V, Defontaines B, Jung P, Degos CF.

Rev Neurol (Paris). 2002 Feb;158(2):225-9. French.

PMID:
11965181
8.

Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.

Poll-The BT, Skjeldal OH, Stokke O, Poulos A, Demaugre F, Saudubray JM.

Hum Genet. 1989 Jan;81(2):175-81.

PMID:
2463966
9.

Disorders related to the metabolism of phytanic acid.

Stokke O, Skjeldal OH, Høie K.

Scand J Clin Lab Invest Suppl. 1986;184:3-10. Review.

PMID:
2438746
10.

Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.

Skjeldal OH, Stokke O, Refsum S, Norseth J, Petit H.

J Neurol Sci. 1987 Jan;77(1):87-96.

PMID:
2433405
11.

Identification of genetic heterogeneity in Refsum's disease.

Wierzbicki AS, Mitchell J, Lambert-Hammill M, Hancock M, Greenwood J, Sidey MC, de Belleroche J, Gibberd FB.

Eur J Hum Genet. 2000 Aug;8(8):649-51.

12.

Structural and mechanistic studies on the peroxisomal oxygenase phytanoyl-CoA 2-hydroxylase (PhyH).

Schofield CJ, McDonough MA.

Biochem Soc Trans. 2007 Nov;35(Pt 5):870-5. Review.

PMID:
17956235
13.

Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?

Foulon V, Asselberghs S, Geens W, Mannaerts GP, Casteels M, Van Veldhoven PP.

J Lipid Res. 2003 Dec;44(12):2349-55. Epub 2003 Aug 16.

15.

Identification of PAHX, a Refsum disease gene.

Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ.

Nat Genet. 1997 Oct;17(2):185-9.

PMID:
9326939
16.

Refsum's disease may mimic familial Guillain Barre syndrome.

Verny C, Prundean A, Nicolas G, Pautot V, Maugin D, Levade T, Bonneau D, Dubas F.

Neuromuscul Disord. 2006 Nov;16(11):805-8. Epub 2006 Aug 23.

PMID:
16934464
17.

Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism.

Lloyd MD, Mukherji M, Kershaw NJ, Chien W, Wierzbicki AS, Schofield CJ.

Adv Exp Med Biol. 2003;544:303-4. No abstract available.

PMID:
14713244
18.
19.

Effect of phytanic acid on cultured retinal pigment epithelium: an in vitro model for Refsum's disease.

Bernstein PS, Lloyd MB, O'Day WT, Bok D.

Exp Eye Res. 1992 Dec;55(6):869-78.

PMID:
1283128
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk